A variety of BRCA1-proficient tumour types also display high levels of nuclear RAD51 without DNA damage induction (10,11), which suggests a role for RAD51 overexpression in tumorigenesis and possibly chemotherapy resistance (7,9). This evidence concerns the gene RAD51 and neoplasm.